Wall Street is positive on 10X Genomics Inc (TXG). On average, analysts give the stock a Buy rating. The average price target is $52.6, which means analysts expect the stock to increase by 7.61% over the next twelve months. That average ranking earns the stock an Analyst Rating of 31, which is better than 31% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating TXG a Buy today. Find out what this means to you and get the rest of the rankings on TXG!